Centene Corp. (NYSE:CNC) is one of the most oversold S&P 500 stocks so far in 2025. On July 2, Centene’s share price plunged ...

Centene is trading at half of book value and under 9x earnings, an extreme undervaluation for a cash-generating insurer. See ...

Fintel reports that on July 21, 2025, TD Cowen downgraded their outlook for Centene (NYSE:CNC) from Buy to Hold. Analyst ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Centene fell by 11.1 percent week-on-week, from $31.44 on July 11 to $27.95 last Friday—a new all-time low, as investors turned cautious ahead of its second quarter earnings results, further ...

The Clayton-based health giant is likely to face increased challenges as federal government tightens Medicaid eligibility and ...

Wall Street Now Sees a More Attractive Valuation in Centene The MarketBeat consensus price target on Centene is nearly $69, implying 107% upside from the stock’s June 3 closing price.

This week in health care business news: How Trump's tax-cut bill will leave people uninsured, Centene takes a tumble, examining UnitedHealth's rates.

Centene’s stock suffers a historic plunge as underestimation of healthcare costs leads the insurer to withdraw its full-year earnings outlook.

Centene (NYSE:CNC – Get Free Report) had its price target reduced by equities researchers at Cantor Fitzgerald from $90.00 to $65.00 in a research note issued to investors on Wednesday,Benzinga ...